DJIA 16,102.38 -272.38 -1.66%
NASDAQ 4,683.92 -49.58 -1.05%
S&P 500 1,921.22 -29.91 -1.53%
market minute promo

PTC Therapeutics, Inc. (NASDAQ: PTCT)

38.03 0.19 (0.50%)

Quote as of


company name or ticker

Recent Quotes

PTCT $38.03 0.50%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.37
Previous Close $37.84
Daily Range $36.68 - $38.42
52-Week Range $29.08 - $78.72
Market Cap $1.3B
P/E Ratio -9.80
Dividend (Yield) $0.00 (0.0%)
Volume 295,514
Average Daily Volume 735,822
Current FY EPS -$4.55

Sector

Industry

PTC Therapeutics, Inc. (PTCT) Description

PTC Therapeutics, Inc. Website: http://www.ptcbio.com/

News & Commentary

3 Soaring Clinical-Stage Biotechs, and 1 to Buy

One Motley Fool digs into three top performing biotech stocks and discovers one that may still be worth buying.

PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient

PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award

Michael Price Invests in Kearny Financial in Second Quarter

Predicting the Outcome of the Biomarin and Sarepta FDA Drug Reviews

Health Care Sector Update for 08/25/2015: PTCT,ADAT,VWR

PTC Therapeutics (PTCT) Is Strong On High Volume Today

Citi Starts PTC Therapeutics At Buy, Sees One Of Year's Biggest Binary Events Coming

Treating Female Sexual Dysfunction (And How To Invest In It)

‘Female Viagra’ approval seen as positive for Sarepta, BioMarin

Perilous Reversal Stock: PTC Therapeutics (PTCT)

PTC Therapeutics Becomes Oversold

See More PTCT News...